By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Evaluation, Diagnosis, and Management of Facioscapulohumeral Muscular Dystrophy
Overview
This updated guideline from the American Academy of Neurology and American Association of Neuromuscular & Electrodiagnostic Medicine revises the 2015 recommendations for the evaluation, diagnosis, prognostication, and treatment of facioscapulohumeral muscular dystrophy. A patient-friendly summary and educational materials for clinicians are also available on their website.
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: July 12, 2024
Contact: practice@apta.org
Content Type: CPG
Young Adult (19-24), Child (6-12), Adolescent (13-18), Adult (25-44)
You Might Also Like...
CPG
Respiratory Management of Patients With Neuromuscular WeaknessMar 13, 2023
This joint guideline by the American College of Chest Physicians and Canadian Thoracic Society covers the prevention of acute exacerbations experienced
Clinical Summary
Muscular Dystrophy (MD): Duchenne and Becker (DBMD)Jan 19, 2014
PTs help people with DBMD improve their quality of life.